| Literature DB >> 30608050 |
Nusrat Najnin1,2, Karin Leder1, Andrew Forbes1, Leanne Unicomb2, Peter J Winch3, Pavani K Ram4, Fosiul A Nizame2, Shaila Arman2, Farzana Begum2, Shwapon Biswas5,2, Alejandro Cravioto6,2, Stephen P Luby7,2.
Abstract
We assessed the impact of handwashing promotion on reported respiratory illness as a secondary outcome from among > 60,000 low-income households enrolled in a cluster-randomized trial conducted in Bangladesh. Ninety geographic clusters were randomly allocated into three groups: cholera-vaccine-only; vaccine-plus-behavior-change (handwashing promotion and drinking water chlorination); and control. Data on respiratory illness (fever plus either cough or nasal congestion or breathing difficulty within previous 2 days) and intervention uptake (presence of soap and water at handwashing station) were collected through monthly surveys conducted among a different subset of randomly selected households during the intervention period. We determined respiratory illness prevalence across groups and used log-binomial regression to examine the association between respiratory illness and presence of soap and water in the handwashing station. Results were adjusted for age, gender, wealth, and cluster-randomized design. The vaccine-plus-behavior-change group had more handwashing stations with soap and water present than controls (45% versus 25%; P < 0.001). Reported respiratory illness prevalence was similar across groups (vaccine-plus-behavior-change versus control: 2.8% versus 2.9%; 95% confidence interval [CI]: -0.008, 0.006; P = 0.6; cholera-vaccine-only versus control: 3.0% versus 2.9%; 95% CI: -0.006, 0.009; P = 0.4). Irrespective of intervention assignment, respiratory illness was lower among people who had soap and water present in the handwashing station than among those who did not (risk ratioadjusted: 0.82; 95% CI: 0.69-0.98). With modest uptake of the handwashing intervention, we found no impact of this large-scale intervention on respiratory illness. However, those who actually had a handwashing station with soap and water had less illness. This suggests improving the effectiveness of handwashing promotion in achieving sustained behavior change could result in health benefits.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30608050 PMCID: PMC6402932 DOI: 10.4269/ajtmh.18-0644
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345
Figure 1.Handwashing station (includes bucket with tap, bowl, and soapy water bottle). This figure appears in color at .
Figure 2.Study timeline. *For data analysis, we defined the behavioral intervention start date as September 24, 2011, which was the midpoint between the start and end dates of the handwashing intervention rollout. Data collection on respiratory illness and handwashing intervention uptake started from September 2011. **We ceased follow-up of the respiratory illness assessment at this time point.
Figure 3.Participant flow during study period.
Demographic characteristics of individuals and households across the intervention groups during the study intervention period (September 2011–August 2013)*
| Characteristics of individuals | Vaccine-only group ( | Vaccine-plus-behavior-change group ( | Control group ( |
|---|---|---|---|
| Age (mean, SD) (years) | 24 (15.9) | 25 (15.9) | 24 (16.0) |
| ≤ 5 | 11 | 11 | 11 |
| > 5 to 15 | 21 | 20 | 22 |
| > 15 to 50 | 62 | 63 | 61 |
| > 50 | 6 | 6 | 6 |
* Some categories do not sum to 100% because of rounding.
† Other sources of drinking water include well, tube well, bottled water, water vendor, and pond/canal/river.
‡ 1 USD = 77.6568 Bangladesh taka (average exchange rate during 2012).
Figure 4.Reported respiratory illness prevalence within last 2 days across the groups during the intervention period (September 2011–August 2013). *Intervention time period (presented in quarters) started from quarter 2. This figure appears in color at .
Reported respiratory illness prevalence within last 2 days of interview according to age and intervention groups during intervention period (September 2011–August 2013)
| Age | All intervention groups combined ( | Vaccine-only group ( | Vaccine-plus-behavior-change group ( | Control group ( |
|---|---|---|---|---|
| < 5 years | 7.0 | 7.1 | 6.7 | 7.4 |
| > 5 to ≤ 15 years | 1.9 | 2.1 | 1.7 | 2.0 |
| > 15 to ≤ 50 years | 2.5 | 2.6 | 2.5 | 2.4 |
| > 50 years | 2.6 | 2.8 | 2.6 | 2.3 |
| All age groups combined | 2.9 | 3.0 | 2.8 | 2.9 |